Ausgabe 3/2013
Inhalt (30 Artikel)
Evolution of the techniques of radiation therapy in the management of lymphoma
Richard T. Hoppe
Old but new methods in radiation oncology: hyperbaric oxygen therapy
Kazuhiko Ogawa, Kiyotaka Kohshi, Syogo Ishiuchi, Masayuki Matsushita, Naoki Yoshimi, Sadayuki Murayama
The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy
Kyoichi Kaira, Toshiaki Takahashi, Haruyasu Murakami, Takehito Shukuya, Hirotsugu Kenmotsu, Akira Ono, Tateaki Naito, Asuka Tsuya, Yukiko Nakamura, Masahiro Endo, Haruhiko Kondo, Takashi Nakajima, Nobuyuki Yamamoto
Epigallocatechin-3-gallate potentiates curcumin’s ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis
Akiko Kondo, Takashi Takeda, Bin Li, Kenji Tsuiji, Mari Kitamura, Tze Fang Wong, Nobuo Yaegashi
Successful treatment of infants with localized neuroblastoma based on their MYCN status
Tomoko Iehara, Minoru Hamazaki, Tatsuro Tajiri, Yoshifumi Kawano, Michio Kaneko, Hitoshi Ikeda, Hajime Hosoi, Tohru Sugimoto, Tadashi Sawada
Attributes of brain metastases from breast and lung cancer
Kyle Hengel, Gurinder Sidhu, Jai Choi, Jeremy Weedon, Emmanuel Nwokedi, Constantine A. Axiotis, Xianyuan Song, Albert S. Braverman
Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma
Masahiro Kikuchi, Yuji Nakamoto, Shogo Shinohara, Keizo Fujiwara, Hiroshi Yamazaki, Yuji Kanazawa, Risa Kurihara, Ippei Kishimoto, Hiroyuki Harada, Yasushi Naito
Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer
Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara
Set-up errors and planning target volume margins in head and neck cancer radiotherapy: a clinical study of image guidance with on-line cone-beam computed tomography
Francesco Dionisi, Mauro Filippo Palazzi, Francesco Bracco, Maria Grazia Brambilla, Claudia Carbonini, Diego Dario Asnaghi, Angelo Filippo Monti, Alberto Torresin
Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years’ experience in two regional training hospitals in the Netherlands
Frank J. van den Broek, Pim C. Sloots, Jan-Willem D. de Waard, Rudi M. Roumen
Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer
Natsuko Hori, Satoru Iwasa, Hironobu Hashimoto, Takako Yanai, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Kouji Murakoshi, Nobuaki Yokote, Hiroshi Yamamoto, Yasuhiro Shimada
Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis
Terence C. Chua, Winston Liauw, Jing Zhao, David L. Morris
First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital
Yoshinari Ogawa, Katsumi Ikeda, Tetsuo Izumi, Shiho Okuma, Makoto Ichiki, Tetsuro Ikeya, Jyunya Morimoto, Yukio Nishiguchi, Teruyuki Ikehara
Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx
Satoshi Fujii, Hideoki Uryu, Ken Akashi, Kensuke Suzuki, Manabu Yamazaki, Makoto Tahara, Ryuichi Hayashi, Atsushi Ochiai
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma
Chengrun Du, Hongmei Ying, Junjun Zhou, Chaosu Hu, Youwang Zhang
Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial
Hiroji Uemura, Masahiro Yanagisawa, Ichirou Ikeda, Kiyoshi Fujinami, Akira Iwasaki, Sumio Noguchi, Kazumi Noguchi, Yoshinobu Kubota
Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer
Yi Kang, Jiancheng Zhang, Peichun Sun, Jia Shang
Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
Hajime Abe, Tsuyoshi Mori, Yuki Kawai, Hirotomi Cho, Yoshihiro Kubota, Tomoko Umeda, Yoshimasa Kurumi, Tohru Tani
The relationship between urinary bisphenol A levels and meningioma in Chinese adults
Bo Duan, Xuebin Hu, Hongyang Zhao, Jun Qin, Jie Luo
Comparison of pirarubicin-based versus gemcitabine–docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience
Aina He, Weixiang Qi, Yujing Huang, Yuanjue Sun, Zan Shen, Hui Zhao, Yumei Yang, Yang Yao
Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma
Kenta Nakamura, Ryuhei Okuyama, Toshiaki Saida, Hisashi Uhara
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
Sergio Frustaci, Angela Buonadonna, Elisa Turchet, Giuseppe Corona, Gianna Tabaro, GianMaria Miolo, Elena Torrisi, Giovanni Lo Re, Salvatore Tumolo, Giuseppe Toffoli
High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma
Jun Du, Jian-Hua Zheng, Xu-Sheng Chen, Qing Yang, Yan-Hui Zhang, Lei Zhou, Xin Yao
Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer
Osamu Ishizuka, Osamu Nishizawa, Shuji Nishizawa, Tomoya Satoh, Masahisa Wajiki, Hideo Kiyokawa, Yoshihiro Inoue, Shinya Kobayashi, Hiroya Mizusawa, Tatsuo Nakagawa
Treatment of bone metastases before the onset of pain
Luis Costa, Allan Lipton, Peyman Hadji, Yin-Miao Chen, Paris Kosmidis
A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
Kohei Shitara, Akira Sawaki, Keitaro Matsuo, Chihiro Kondo, Daisuke Takahari, Takashi Ura, Masahiro Tajika, Yasumasa Niwa, Kei Muro
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
Hiroyuki Takei, Takashi Yoshida, Masafumi Kurosumi, Kenichi Inoue, Hiroshi Matsumoto, Yuji Hayashi, Toru Higuchi, Sayaka Uchida, Jun Ninomiya, Kazuyuki Kubo, Hanako Oba, Shigenori Nagai, Toshio Tabei
Does long-term treatment with Doxil® predispose patients to oral cancer?
Yehuda Ben-David, Yoav Leiser, Orly Kachta, Imad Abu El-Naaj
Short response duration even in responders to chemotherapy using conventional cytotoxic agents in recurrent or refractory clear cell carcinomas of the ovary
Masashi Takano, Tomoko Goto, Masafumi Kato, Naoki Sasaki, Morikazu Miyamoto, Kenichi Furuya